š¤ AI Summary
This study addresses the challenge of automating the discovery of āinterestingā featureātarget relationshipsāincluding effect direction and underlying biological mechanismsāin structured biomedical data. We formally define āinterestingnessā as a unified metric integrating novelty, utility, and credibility. To this end, we propose an end-to-end hypothesis generation pipeline that synergistically integrates SHAP-based interpretable machine learning, knowledge graph reasoning, literature-based semantic retrieval, and large language modelāassisted validationāenabling cross-disease, target-agnostic, and scalable hypothesis generation and ranking. Evaluated on eight disease cohorts from the UK Biobank, our method retrospectively rediscovered known risk factors years before their clinical recognition. Expert evaluation revealed that 40ā53% of top-ranked hypotheses were deemed interestingāsubstantially outperforming baseline methods (0ā7%). Moreover, 28% of 109 candidate hypotheses received endorsement from domain experts.
š Abstract
Finding interesting phenomena is the core of scientific discovery, but it is a manual, ill-defined concept. We present an integrative pipeline for automating the discovery of interesting simple hypotheses (feature-target relations with effect direction and a potential underlying mechanism) in structured biomedical data. The pipeline combines machine learning, knowledge graphs, literature search and Large Language Models. We formalize"interestingness"as a combination of novelty, utility and plausibility. On 8 major diseases from the UK Biobank, our pipeline consistently recovers risk factors years before their appearance in the literature. 40--53% of our top candidates were validated as interesting, compared to 0--7% for a SHAP-based baseline. Overall, 28% of 109 candidates were interesting to medical experts. The pipeline addresses the challenge of operationalizing"interestingness"scalably and for any target. We release data and code: https://github.com/LinialLab/InterFeat